Refine
Document Type
- Article (4)
Language
- English (4)
Has Fulltext
- yes (4)
Is part of the Bibliography
- no (4)
Keywords
- AEC syndrome (1)
- ATO (1)
- Bioindicators (1)
- Biomonitoring (1)
- Contaminants (1)
- Genetics (1)
- Genome-wide association studies (1)
- IGF (1)
- NOTCH1 (1)
- SARS-CoV-2 (1)
The genetic make-up of an individual contributes to the susceptibility and response to viral infection. Although environmental, clinical and social factors have a role in the chance of exposure to SARS-CoV-2 and the severity of COVID-191,2, host genetics may also be important. Identifying host-specific genetic factors may reveal biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We formed a global network of researchers to investigate the role of human genetics in SARS-CoV-2 infection and COVID-19 severity. Here we describe the results of three genome-wide association meta-analyses that consist of up to 49,562 patients with COVID-19 from 46 studies across 19 countries. We report 13 genome-wide significant loci that are associated with SARS-CoV-2 infection or severe manifestations of COVID-19. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases3,4,5,6,7. They also represent potentially actionable mechanisms in response to infection. Mendelian randomization analyses support a causal role for smoking and body-mass index for severe COVID-19 although not for type II diabetes. The identification of novel host genetic factors associated with COVID-19 was made possible by the community of human genetics researchers coming together to prioritize the sharing of data, results, resources and analytical frameworks. This working model of international collaboration underscores what is possible for future genetic discoveries in emerging pandemics, or indeed for any complex human disease.
Bioindicators are organisms able to provide indirectly or directly information on the impact of pollutants in the environment. The content of heavy metals or other toxic compounds in these living organisms is of great interest to assess the level of contaminants. Leaves of the most common deciduous trees (Acer pseudoplatanus L., Betula pendula Roth, Carpinus betulus L., Cercis siliquastrum L., Ginkgo biloba L., Liquidambar styraciflua, Quercus robur L. and Tilia cordata Miller) and two invasive tree species Ailanthus altissima P. Mill. and Robinia pseudoacacia L., in the City of Bolzano (southern Alps in Northern Italy), were therefore studied to assess their suitability as bioindicators for the trace elements Cd, Cu, Mn, Pb, and Zn, mainly considered as traffic related elements. Leaves and soil samples were investigated, both from high-density traffic roads and control sites of minor traffic impact, such as parks. Our data reveal that Betula pendula has a considerable Zn accumulation potential compared to the other investigated tree species. The maximum value measured for Zn in a Betula specimen is 200 mg kg-1 dry weight. With regard to the soils, considering the geoaccumulation index, most of the analyzed soils belong to the first class, i. e. uncontaminated (Igeo ≤ 0) for all analyzed elements. Moreover, in several samples collected in high traffic areas, Cu and Zn show values within 1 < Igeo ≤ 2 (moderately contaminated). This allows to hypothesize a traffic-related origin for these elements. For this reason, B. pendula can be considered a potential heavy metal accumulator and therefore a good bioindicator for these urban pollutants. Since B. pendula is widely distributed in urban areas in Central and Northern Europe, it can be considered a species suitable for a systematic and comparative monitoring network.
Ceritinib-induced regression of an insulin-like growth factor-driven neuroepithelial brain tumor
(2019)
The insulin-like growth factor (IGF) pathway plays an important role in several brain tumor entities. However, the lack of inhibitors crossing the blood–brain barrier remains a significant obstacle for clinical translation. Here, we targeted the IGF pathway using ceritinib, an off-target inhibitor of the IGF1 receptor (IGF1R) and insulin receptor (INSR), in a pediatric patient with an unclassified brain tumor and a notch receptor 1 (NOTCH1) germline mutation. Pathway analysis of the tumor revealed activation of the sonic hedgehog (SHH), the wingless and integrated-1 (WNT), the IGF, and the Notch pathway. The proliferation of the patient tumor cells (225ZL) was inhibited by arsenic trioxide (ATO), which is an inhibitor of the SHH pathway, by linsitinib, which is an inhibitor of IGF1R and INSR, and by ceritinib. 225ZL expressed INSR but not IGF1R at the protein level, and ceritinib blocked the phosphorylation of INSR. Our first personalized treatment included ATO, but because of side effects, we switched to ceritinib. After 46 days, we achieved a concentration of 1.70 µM of ceritinib in the plasma, and after 58 days, MRI confirmed that there was a response to the treatment. Ceritinib accumulated in the tumor at a concentration of 2.72 µM. Our data suggest ceritinib as a promising drug for the treatment of IGF-driven brain tumors.
Protein aggregation of the p63 transcription factor underlies severe skin fragility in AEC syndrome
(2018)
The p63 gene encodes a master regulator of epidermal commitment, development, and differentiation. Heterozygous mutations in the C-terminal domain of the p63 gene can cause ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome, a life-threatening disorder characterized by skin fragility and severe, long-lasting skin erosions. Despite deep knowledge of p63 functions, little is known about mechanisms underlying disease pathology and possible treatments. Here, we show that multiple AEC-associated p63 mutations, but not those causative of other diseases, lead to thermodynamic protein destabilization, misfolding, and aggregation, similar to the known p53 gain-of-function mutants found in cancer. AEC mutant proteins exhibit impaired DNA binding and transcriptional activity, leading to dominant negative effects due to coaggregation with wild-type p63 and p73. Importantly, p63 aggregation occurs also in a conditional knock-in mouse model for the disorder, in which the misfolded p63 mutant protein leads to severe epidermal defects. Variants of p63 that abolish aggregation of the mutant proteins are able to rescue p63’s transcriptional function in reporter assays as well as in a human fibroblast-to-keratinocyte conversion assay. Our studies reveal that AEC syndrome is a protein aggregation disorder and opens avenues for therapeutic intervention.